In the final rule, CMS repeatedly expressed that it will continue to evaluate and monitor patient safety, access, safeguards, and other topics related to remote direct supervision. Healthcare ...

Needham analyst Michael Matson maintained a Hold rating on Masimo (MASI – Research Report) today. The company’s shares closed ...

Q3 2024 Earnings Conference Call November 5, 2024 4:30 PM ETCompany ParticipantsEli Kammerman - VP of Business ...

The consensus rating for Masimo is Buy, based on 2 analyst ratings. With an average one-year price target of $167.5, there's a potential 16.14% upside.

A variety of medical device innovations and diagnostics have been named by Time as some of the best inventions of 2024.

Masimo MASI2.83%increase; green up pointing triangle said Joe Kiani, who previously informed the board of his decision to resign as chief executive, has been terminated by the company. Kiani’s ...

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. TipRanks is the most comprehensive data set of sell side ...

Masimo (NASDAQ:MASI) Corporation (NASDAQ:MASI), a medical technology company, has announced the termination of its Chief Executive Officer, Joe Kiani, effective October 24, 2024. The decision was ...

Masimo (MASI) announced that Vanderbilt University Medical Center VUMC , a renowned healthcare facility in Nashville, Tennessee, is piloting ...

Vanderbilt University Medical Center is launching Masimo Radius VSM™ advanced wireless patient-worn vital signs monitoring ...

Masimo has filed a lawsuit against its founder and former CEO Joe Kiani and investment firm RTW Investments, accusing them of illegally manipulating a recent shareholder vote. The suit, filed in ...